Brands: Provera · Medroxyprogesterone Acetate
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 10 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 6 | SUPPLYING |
| Proficient Rx LP | repackager | 6 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | generic | 6 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 5 | SUPPLYING |
| A-S Medication Solutions | repackager | 4 | SUPPLYING |
| Pharmacia & Upjohn Company LLC | unknown | 3 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 3 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 2 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
| Coupler LLC | repackager | 1 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Medroxyprogesterone Acetate Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Urology.
Medroxyprogesterone Acetate Tablet — reported in shortage by Pfizer Inc.. Therapeutic category: Urology.
